Percentages of Foxp-3+ HA-specific CD4+ T cells in the lungs were comparable among the mice with no treatment, with Oseltamivir only and with combinations of Oseltamivir and Rapamycin on day 7- post infection (Fig. 5c). This evidence concerns the gene CD4 and infection.